Trailing-twelve-month (TTM) revenue is $22.37 Billion with a year-over-year growth of +0.63%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,600,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-24 |
| Q4 FY2025Period ended 2025-12-31 | $5,657,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-06 |
| Q1 FY2026Period ended 2026-03-31 | $5,402,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-24 |
| Q2 FY2026Period ended 2026-06-30 | $5,714,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-24 |
| TTM revenue | $22,373,000,000 |
Current P/S: $27,442,815,595 market capitalization ÷ $22,373,000,000 TTM revenue = 1.23x.
Market capitalization source: FMP quote. Quote observed 2026-09-22T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $5.71B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T00:15:43.283Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Completion And Production | $7.8B | $8.4B | $11.6B | $13.7B | $13.3B | $12.8B |
| Drilling And Evaluation | $6.6B | $6.9B | $8.7B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Europe/Africa/CIS | $2.8B | $2.7B | $2.7B | $2.9B | $3.0B | $3.4B |
| Latin America | $1.7B | $2.4B | $3.2B | $4.0B |
$22.37B
$22.37 Billion
+0.63%
vs. $22.23B a year ago (TTM)
+10.85%
5 Year compound annual growth rate
1 Year
+0.63%
3 Year
(0.06%)
5 Year
+10.85%
10 Year
+1.81%
15 Year
(0.17%)
20 Year
+1.44%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $22.18B | ($760.00M) | (3.31%) |
| 2024 | $22.94B | ($74.00M) | (0.32%) |
| 2023 | $23.02B | +$2.72B | +13.41% |
| 2022 | $20.30B | +$5.00B | +32.70% |
| 2021 | $15.29B | +$850.00M | +5.88% |
| 2020 |
TTM Growth
+0.63%
3-Year CAGR
(0.06%)
5-Year CAGR
+10.85%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T00:15:43.283Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $9.7B |
| $9.4B |
| $4.2B |
| $3.9B |
| Middle East/Asia | $4.2B | $3.8B | $4.8B | $5.7B | $6.1B | $5.8B |
|---|
| North America | $5.7B | $6.4B | $9.6B | $10.5B | $9.6B | $9.1B |
|---|
| $14.45B |
| ($7.96B) |
| (35.54%) |
| 2019 | $22.41B | ($1.59B) | (6.61%) |
| 2018 | $24.00B | +$3.38B | +16.37% |
| 2017 | $20.62B | +$4.73B | +29.79% |
| 2016 | $15.89B | ($7.75B) | (32.78%) |
